6 key areas impacted in today’s COVID and Decentralized Clinical Trial environment
| This week's Fierce LifeSci Weekly is brought to you by RxE2.
Trouble viewing? Click here. |
| Date: Tuesday, February 23, 2021 Time: 1pm ET / 10am PT Duration: 1 Hour |
|
| This webinar will focus on how a pharmacist-led clinical trial model impacts the six key areas most relevant to clinical trials in today’s COVID and Decentralized Clinical Trial environment.
Regulation: GMP and GCP regulations versus state healthcare regulations Recruiting: Clinical research participation as a healthcare option for all patients Diversity: Reach everyone, everywhere Clinical Outcomes: The impact of the CTRP® and their relationship with patients Data Integrity: The technology platform needed to support grand scale, pharmacist-led clinical trials + The role of the pharmacist in clinical trials: to collect subjective data and to provide the context of objective data Clinical Supply Chain: Cost effective DCT and DtP model + Regulatory requirements
|
|
|
You are currently subscribed as [email protected]
If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe.
Refer to our Privacy Policy.
Fierce LifeSciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
© 2020 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. |
|
|
